classifying xylazine as a schedule III controlled drug.

Latest action: Inexpedient to Legislate: MA VV 04/23/2026 HJ 11 P. 55

Voted 4/23/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

4/23/2026Inexpedient to Legislate: MA VV 04/23/2026 HJ 11 P. 55
4/23/2026Inexpedient to Legislate: MA VV 04/23/2026 HJ 11
4/15/2026Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; RC)
4/15/2026Minority Committee Report: Ought to Pass
4/8/2026Executive Session: 04/14/2026 01:00 pm GP 153
4/1/2026Full Committee Work Session: 04/07/2026 01:00 pm GP 153
3/18/2026Public Hearing: 03/31/2026 01:30 pm GP 153
3/16/2026Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture HJ 8 P. 114
3/16/2026Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture HJ 8
2/24/2026Committee Amendment # 2026-0842s, AA, VV; 03/05/2026; SJ 5